Report of unscheduled material events or corporate event Submitted by amarin on Wed, 04/11/2018 - 19:44 Home Read more about Report of unscheduled material events or corporate event
Annual report which provides a comprehensive overview of the company for the past year Submitted by amarin on Wed, 04/11/2018 - 19:44 Home Read more about Annual report which provides a comprehensive overview of the company for the past year
Statement of changes in beneficial ownership of securities Submitted by amarin on Wed, 04/11/2018 - 19:44 Home Read more about Statement of changes in beneficial ownership of securities
Statement of changes in beneficial ownership of securities Submitted by amarin on Wed, 04/11/2018 - 19:44 Home Read more about Statement of changes in beneficial ownership of securities
Amarin to Present at the H.C. Wainwright Annual Global Life Sciences Conference Submitted by amarin on Wed, 04/11/2018 - 19:44 Home Read more about Amarin to Present at the H.C. Wainwright Annual Global Life Sciences Conference
Amarin Sponsors Two Scientific Presentations Scheduled for National Kidney Foundation 2018 Spring Clinical Meetings Submitted by amarin on Wed, 04/11/2018 - 19:44 Home Read more about Amarin Sponsors Two Scientific Presentations Scheduled for National Kidney Foundation 2018 Spring Clinical Meetings
Amarin's REDUCE-IT Cardiovascular Outcomes Study Reaches 100% Mark for Estimated Onset of Target Primary Major Adverse Cardiovascular Events Submitted by amarin on Wed, 04/11/2018 - 19:44 Home Read more about Amarin's REDUCE-IT Cardiovascular Outcomes Study Reaches 100% Mark for Estimated Onset of Target Primary Major Adverse Cardiovascular Events
Amarin Updates First Quarter Revenue Guidance, Reiterates Full Year Guidance and Updates on REDUCE-IT Cardiovascular Outcomes Study Progress and Vascepa® Promotion Initiatives Submitted by amarin on Wed, 04/11/2018 - 19:44 Home Read more about Amarin Updates First Quarter Revenue Guidance, Reiterates Full Year Guidance and Updates on REDUCE-IT Cardiovascular Outcomes Study Progress and Vascepa® Promotion Initiatives
Amarin to Report Fourth Quarter and Full Year 2017 Results and Host Conference Call on February 27th, 2018 Submitted by amarin on Wed, 04/11/2018 - 19:44 Home Read more about Amarin to Report Fourth Quarter and Full Year 2017 Results and Host Conference Call on February 27th, 2018
